Dermagnostix announces acquisition and continuation of the fluorescence detector technology of Dialunox as of July 1st 2025
Freiburg im Breisgau, 05.05.2025 – The Dermagnostix GmbH from Freiburg, specialized on the development of molecular diagnostic tests for dermatology,…
5. May 2025